Ocuphire Pharma Alternatives & Competitors

12 companies similar to Ocuphire Pharma — Restoring Vision and Clarity

Realm Therapeutics, Inc.

2 Post-IPO Equity $26.00M

Malvern, United States

Biotechnology Pharmaceutical

PaxMedica, Inc.

Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...

7 Post-IPO Equity $30.68M

Tarrytown, United States

Biotechnology Pharmaceutical

Theratechnologies Inc.

Health innovation that matters | #HIV #NASH #Oncology

98 Post-IPO Equity $216.26M

Montreal, Canada

Biotechnology Pharmaceutical

MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with str...

Post-IPO Equity $136.00M

Biotechnology Health and Wellness +1

Track all Ocuphire Pharma competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

Inventiva Pharma

A clinical-stage biopharmaceutical company focused on the development of oral small molecu...

108 Post-IPO Equity $276.30M

France

Biopharma Biotechnology +1

ONL Therapeutics

Helping patients see the future

39 Venture round

Ann Arbor, United States

Biotechnology Health Care +2

Terns Pharmaceuticals

Taking the Journey Towards Comprehensive Treatment of Serious Disease

63 Post-IPO Equity $348.30M

Foster City, United State...

Biotechnology Health Care +2

Omeros Corporation

Let science lead the way

234 Grant $819.98M

Seattle, United States

Biotechnology Health Care +1

Tetralogic Pharmaceuticals

10 Convertible Note $164.00M

Biotechnology Health Care +1

Reistone Biopharma

Focusing on rapidly developing innovative medicines through global collaborations within R...

52 Series A $100.00M

China

Biotechnology Pharmaceutical

About Ocuphire Pharma

Ocuphire Pharma is a late-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for retinal and refractive disorders. Founded in 2018, the company operates in the Biopharma, Biotechnology, and Pharmaceutical industries. With the slogan "Restoring Vision and Clarity," Ocuphire's...

Business keywords

Ophthalmic Biopharmaceutical, Retinal Disorders, Refractive Disorders, Small-molecule Product Candidates, Late-stage, Therapy Development, Commercialization, Vision Care, Drug Development, Ophthalmology, Clinical Trials, Unmet Medical Needs

Frequently Asked Questions

Companies similar to Ocuphire Pharma include Realm Therapeutics, Inc., PaxMedica, Inc., Theratechnologies Inc., MediciNova, ORIC Pharmaceuticals Inc.. They work in Biotechnology and Pharmaceutical and share Ocuphire Pharma's focus on drug development, unmet medical needs and clinical trials.

Bounce Watch lists 12 companies that share Ocuphire Pharma's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Ocuphire Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Ocuphire Pharma Profile PaxMedica, Inc. Alternatives ORIC Pharmaceuticals Inc. Alternatives Reviva Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Ocuphire Pharma on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 18 Sep 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.